Home Cart Sign in  
Chemical Structure| 151411-13-1 Chemical Structure| 151411-13-1

Structure of 151411-13-1

Chemical Structure| 151411-13-1

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 151411-13-1 ]

CAS No. :151411-13-1
Formula : C12H10F2N2O
M.W : 236.22
SMILES Code : FC1=C(C(F)=CC=C1)COC2=C(N)N=CC=C2
MDL No. :MFCD29086868

Safety of [ 151411-13-1 ]

Application In Synthesis of [ 151411-13-1 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 151411-13-1 ]

[ 151411-13-1 ] Synthesis Path-Downstream   1~1

  • 1
  • [ 151411-13-1 ]
  • [ 33142-21-1 ]
  • [ 1609165-62-9 ]
YieldReaction ConditionsOperation in experiment
2.02 g In ethanol;Reflux; Example 30A Ethyl 8-[(2,6-difluorobenzyl)oxy]imidazo[1,2-a]pyridine-3-carboxylate 1.93 g of 3-[(2,6-difluorobenzyl)oxy]pyridine-2-amine (Example 4A; 8.2 mmol, 1 equivalent) were initially charged in 50 ml of ethanol, and 8.2 g of <strong>[33142-21-1]ethyl 2-chloro-3-oxopropanoate</strong> (75% pure, crude product from Example 29A, 40.8 mmol, 5 equivalents) were added. The resulting reaction mixture was heated at reflux overnight. The reaction solution was concentrated and the crude product obtained was chromatographed on 340 g of silica gel (Biotage Isolera) (mobile phase: cyclohexane:ethyl acetate gradient; Rf value of the product in cyclohexane:ethyl acetate 2:1=0.36). The product fractions were combined and concentrated and the residue obtained was triturated with diisopropyl ether. The solid was filtered off and dried under high vacuum. This gave 2.02 g of the title compound (71% of theory). LC-MS (Method 1): Rt=1.08 min MS (ESpos): m/z=333.1 (M+H)+ 1H NMR (400 MHz, DMSO-d6): delta=1.35 (t, 3H); 4.39 (q, 2H); 5.35 (s, 2H); 7.15-7.28 (m, 4H); 7.58 (quint., 1H); 8.18 (s, 1H); 8.90 (d, 1H).
2.02 g In ethanol;Reflux; Example 27A Ethyl 8-[(2,6-difluorobenzyl)oxy]imidazo[1,2-a]pyridine-3-carboxylate 1.93 g of 3-[(2,6-difluorobenzyl)oxy]pyridine-2-amine (Example 1A; 8.2 mmol, 1 equivalent) were initially charged in 50 ml of ethanol, and 8.2 g of <strong>[33142-21-1]ethyl 2-chloro-3-oxopropanoate</strong> (75% pure, crude product from Example 26A, 40.8 mmol, 5 equivalents) were added. The reaction mixture was heated at reflux overnight. The mixture was then concentrated under reduced pressure and the crude product obtained was chromatographed on 340 g of silica gel (Biotage Isolera) (mobile phase: cyclohexane:ethyl acetate gradient; Rf value of the product in cyclohexane:ethyl acetate 2:1=0.36). The product fractions were combined and concentrated and the residue obtained was triturated with diisopropyl ether. The solid was filtered off and dried under high vacuum. This gave 2.02 g of the title compound (71% of theory). LC-MS (Method 2): Rt=1.08 min MS (ESpos): m/z=333.1 (M+H)+ 1H NMR (400 MHz, DMSO-d6): delta=1.35 (t, 3H); 4.39 (q, 2H); 5.35 (s, 2H); 7.15-7.28 (m, 4H); 7.58 (q, 1H); 8.18 (s, 1H); 8.90 (d, 1H).
2.02 g Reflux; Example 31A Ethyl 8-[(2,6-difluorobenzyl)oxy]imidazo[1,2-a]pyridine-3-carboxylate 1.93 g of 3[(2,6-difluorobenzyl)oxy]pyridine-2-amine (Example 1A; 8.2 mmol, 1 equivalent) were initially charged in 50 ml of ethanol, and 8.2 g of <strong>[33142-21-1]ethyl 2-chloro-3-oxopropanoate</strong> (purity 75%, crude product from Example 30A, 40.8 mmol, 5 equivalents) were added. The reaction mixture was heated at reflux overnight. The mixture was then concentrated under reduced pressure and the crude product obtained was chromatographed on 340 g of silica gel (Biotage Isolera)?(mobile phase: cyclohexane:ethyl acetate gradient; Rf of the product in cyclohexane:ethyl acetate 2:1=0.36). The product fractions were combined and concentrated, and the residue obtained was stirred with diisopropyl ether. The solid was filtered off and dried under high vacuum. This gave 2.02 g of the title compound (71% of theory). (0656) LC-MS (Method 1): Rt=1.08 min (0657) MS (ESpos): m/z=333.1 (M+H)+ (0658) 1H-NMR (400 MHz, DMSO-d6): delta=1.35 (t, 3H), 4.39 (q, 2H), 5.35 (s, 2H), 7.15-7.28 (m, 4H), 7.58 (q, 1H), 8.18 (s, 1H), 8.90 (d, 1H).
Example 31A Ethyl 8-[(2,6-difluorobenzyl)oxy]imidazo[1,2-a]pyridine-3-carboxylate 1.93 g of 3[(2,6-difluorobenzyl)oxy]pyridine-2-amine (Example 1A; 8.2 mmol, 1 equivalent) were initially charged in 50 ml of ethanol, and 8.2 g of <strong>[33142-21-1]ethyl 2-chloro-3-oxopropanoate</strong> (purity 75%, crude product from Example 30A, 40.8 mmol, 5 equivalents) were added. The reaction mixture was heated at reflux overnight. The mixture was then concentrated under reduced pressure and the crude product obtained was chromatographed on 340 g of silica gel (Biotage Isolera) (mobile phase: cyclohexane:ethyl acetate gradient; Rf of the product in cyclohexane:ethyl acetate 2:1=0.36). The product fractions were combined and concentrated, and the residue obtained was stirred with diisopropyl ether.

 

Historical Records